M Braoudaki

Summary

Country: UK

Publications

  1. pmc Protein biomarkers distinguish between high- and low-risk pediatric acute lymphoblastic leukemia in a tissue specific manner
    Maria Braoudaki
    First Department of Pediatrics, University of Athens Medical School, Choremeio Research Laboratory, Thivon and Levadias 11527 Goudi Athens, Greece
    J Hematol Oncol 6:52. 2013
  2. doi request reprint Clinical cytogenetics in pediatric acute leukemia: an update
    Maria Braoudaki
    University Research Institute for the Study and Treatment of Childhood Genetic and Malignant Diseases, University of Athens, Aghia Sophia Children s Hospital, Athens, Greece
    Clin Lymphoma Myeloma Leuk 12:230-7. 2012
  3. doi request reprint Frequency of FLT3 mutations in childhood acute lymphoblastic leukemia
    M Braoudaki
    Hematology Oncology Unit, First Department of Pediatrics, University of Athens, Aghia Sophia Children s Hospital, Thivon and Levadias, Goudi Athens, 11527 Athens, Greece
    Med Oncol 26:460-2. 2009
  4. pmc The frequency of NPM1 mutations in childhood acute myeloid leukemia
    Maria Braoudaki
    University Research Institute for the Study and Treatment of Childhood Genetic and Malignant Diseases, University of Athens, Aghia Sophia Children s Hospital, Athens, Greece
    J Hematol Oncol 3:41. 2010
  5. doi request reprint Analysis of somatic hypermutations of immunoglobulin gene rearrangements in childhood acute lymphoblastic leukemia
    M Braoudaki
    University Research Institute for the Study and Treatment of Childhood Genetic and Malignant Diseases, Hematology Oncology Unit, First Department of Pediatrics, Aghia Sophia Children s Hospital, University of Athens, Athens, Greece
    Cancer Invest 29:360-4. 2011
  6. ncbi request reprint Tumorigenesis related to retroviral infections
    Maria Braoudaki
    University Research Institute for the Study and Treatment of Childhood Genetic and Malignant Diseases, University of Athens, Aghia Sophia Children s Hospital, Athens, Greece
    J Infect Dev Ctries 5:751-8. 2011
  7. ncbi request reprint Evaluation of antitumor activity of gefitinib in pediatric glioblastoma and neuroblastoma cells
    K Hatziagapiou
    Hematology Oncology Unit, First Department of Pediatrics, University of Athens, Aghia Sophia Children s Hospital, Athens, Greece
    Clin Lab 57:781-4. 2011

Detail Information

Publications7

  1. pmc Protein biomarkers distinguish between high- and low-risk pediatric acute lymphoblastic leukemia in a tissue specific manner
    Maria Braoudaki
    First Department of Pediatrics, University of Athens Medical School, Choremeio Research Laboratory, Thivon and Levadias 11527 Goudi Athens, Greece
    J Hematol Oncol 6:52. 2013
    ..In addition, vitronectin and plasminogen probably contributed to leukemogenesis, whilst bicaudal D-related protein 1 could afford a significant biomarker for pediatric ALL therapeutics. ..
  2. doi request reprint Clinical cytogenetics in pediatric acute leukemia: an update
    Maria Braoudaki
    University Research Institute for the Study and Treatment of Childhood Genetic and Malignant Diseases, University of Athens, Aghia Sophia Children s Hospital, Athens, Greece
    Clin Lymphoma Myeloma Leuk 12:230-7. 2012
    ..In the present review, the clinical significance of most chromosomal aberrations associated with pediatric ALL and AML as well as the current technology used for their identification is discussed...
  3. doi request reprint Frequency of FLT3 mutations in childhood acute lymphoblastic leukemia
    M Braoudaki
    Hematology Oncology Unit, First Department of Pediatrics, University of Athens, Aghia Sophia Children s Hospital, Thivon and Levadias, Goudi Athens, 11527 Athens, Greece
    Med Oncol 26:460-2. 2009
    ..This is in accordance to previous studies indicating a higher incidence in the patient subgroup associated with hyperdiploidy...
  4. pmc The frequency of NPM1 mutations in childhood acute myeloid leukemia
    Maria Braoudaki
    University Research Institute for the Study and Treatment of Childhood Genetic and Malignant Diseases, University of Athens, Aghia Sophia Children s Hospital, Athens, Greece
    J Hematol Oncol 3:41. 2010
    ..We evaluated the frequency of NPM1 mutations in childhood AML, their relation to clinical and cytogenetic features and the presence of common FLT3 and RAS mutations...
  5. doi request reprint Analysis of somatic hypermutations of immunoglobulin gene rearrangements in childhood acute lymphoblastic leukemia
    M Braoudaki
    University Research Institute for the Study and Treatment of Childhood Genetic and Malignant Diseases, Hematology Oncology Unit, First Department of Pediatrics, Aghia Sophia Children s Hospital, University of Athens, Athens, Greece
    Cancer Invest 29:360-4. 2011
    ..A higher frequency of somatic hypermutations was noted in unproductive rearrangements and was generally attributed to nucleotide mutation type, region, and IGHV gene subgroup biases...
  6. ncbi request reprint Tumorigenesis related to retroviral infections
    Maria Braoudaki
    University Research Institute for the Study and Treatment of Childhood Genetic and Malignant Diseases, University of Athens, Aghia Sophia Children s Hospital, Athens, Greece
    J Infect Dev Ctries 5:751-8. 2011
    ..Finally, the impact of cancer-related retroviral infections in the developing world is addressed. This review is an update of carcinogenesis caused by retroviral infections...
  7. ncbi request reprint Evaluation of antitumor activity of gefitinib in pediatric glioblastoma and neuroblastoma cells
    K Hatziagapiou
    Hematology Oncology Unit, First Department of Pediatrics, University of Athens, Aghia Sophia Children s Hospital, Athens, Greece
    Clin Lab 57:781-4. 2011
    ..This work was undertaken to investigate the efficacy of gefitinib, an EGFR tyrosine kinase inhibitor, in tumor cell lines of the CNS by studying cell proliferation and phosphorylation of the tyrosine kinase domain of..